| Lucinda Bennett, | |
|
111 W High St, Elkton, MD 21921-5529 | |
| (410) 398-4000 | |
| Not Available |
| Full Name | Lucinda Bennett |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 111 W High St, Elkton, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164510467 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 05214 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lucinda Bennett, 129 Tidewater Dr, Havre De Grace, MD 21078-4140 Ph: (410) 939-2099 | Lucinda Bennett, 111 W High St, Elkton, MD 21921-5529 Ph: (410) 398-4000 |
News Archive
Firefighter deaths due to heart attacks may not be due to bad diets, but from exposure to hydrogen cyanide in fire smoke. Nationally, six firefighters have literally dropped dead from heart attacks after coming off of a shift of smoky fires and more than 100 were treated or hospitalized for smoke inhalation since January 1.
Shining a laser light on cells and then clicking off the light makes the cells "breathe in" surrounding water, providing a potentially powerful delivery system for chemotherapy drugs, as well as a non-invasive way to target anti-Alzheimer's medicines to the brain. That's the conclusion of a report in ACS's The Journal of Physical Chemistry Letters.
An aging population poses challenges for governments around the globe as nations grapple with how to satisfy the physical, social and economic needs of older adults.
Concert Medical, LLC today announced the launch of the "Conductorâ„¢" family of Interventional Coronary Guidewires to the U.S. market. These guidewires are designed to address an extensive range of coronary disease cases at a superior value. The FDA granted Concert Medical clearance for the use and sale in the U.S. of the Conductor product line in September 2009.
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
› Verified 9 days ago
Union Hospital Of Cecil County Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 W High St Ste 303, Elkton, MD 21921 Phone: 410-392-2380 Fax: 410-392-3234 | |
Heidi Grieb-ginn, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 111 W High St, Suite 112, Elkton, MD 21921 Phone: 410-398-4000 | |
Miss Kelley Breheny, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Booth St, Elkton, MD 21921 Phone: 540-099-6410 | |
Devon Reed, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 203 E Thomson Dr, Elkton, MD 21921 Phone: 410-996-5080 | |
Erica Mccreary, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Booth St, Elkton, MD 21921 Phone: 410-996-5450 | |
Mrs. Maureen Patrice Quinlan, MS-CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Booth St, Elkton, MD 21921 Phone: 410-996-5450 | |
Marcia Adams, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Booth St, Elkton, MD 21921 Phone: 410-996-9400 |